World's Best Scientists 2026 revealed!
Philippe Gevaert

Philippe Gevaert

D-Index & Metrics

Immunology

D-Index
81
Citations
34559
World Ranking
1538
National Ranking
19

Philippe Gevaert publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Philippe Gevaert sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 276 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Philippe Gevaert D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Philippe Gevaert sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Philippe Gevaert is a researcher affiliated with Ghent University in Belgium. Their work primarily focuses on the field of Medicine, with a strong emphasis on Immunology and Allergy, Otorhinolaryngology, and Physiology. The research covers clinical and physiological aspects of respiratory diseases, allergic conditions, and nasal disorders.

The main topics explored in their publications include:

  • Allergic Rhinitis and Sensitization
  • Sinusitis and nasal conditions
  • Asthma and respiratory diseases
  • Nasal Surgery and Airway Studies
  • Olfactory and Sensory Function Studies
  • Respiratory and Cough-Related Research
  • Infectious Diseases and Mycology

Gevaert has contributed to a number of peer-reviewed papers, including the following recent works:

  • "European Position Paper on Rhinosinusitis and Nasal Polyps 2020" (2020), published in Rhinology Journal
  • "Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials" (2020), published in Journal of Allergy and Clinical Immunology
  • "EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management" (2020), published in Journal of Allergy and Clinical Immunology
  • "Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial" (2021), published in Journal of Allergy and Clinical Immunology
  • "EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023" (2023), published in Rhinology Journal

Frequently collaborating co-authors include:

  • Peter W. Hellings
  • Claus Bachert
  • Joaquim Mullol
  • Wytske J. Fokkens
  • Sanna Toppila-Salmi

The most frequent venues for their work include:

  • Journal of Allergy and Clinical Immunology
  • Allergy
  • The Journal of Allergy and Clinical Immunology In Practice
  • Rhinology Journal
  • Frontiers in Allergy

Philippe Gevaert's research contributions span clinical trials, expert consensus papers, and updates on therapeutic strategies, especially in relation to chronic rhinosinusitis, nasal polyps, and biologic treatments. Their work supports advancing understanding and management of respiratory and allergic diseases within otorhinolaryngology and immunology.

Best Publications

  • EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

    Wytske J. Fokkens;Valerie J. Lund;Joachim Mullol;Claus Bachert

  • European Position Paper on Rhinosinusitis and Nasal Polyps 2020

    Wytske J. Fokkens;Valerie J. Lund;Joachim Mullol;Claus Bachert

  • Differentiation of chronic sinus diseases by measurement of inflammatory mediators.

    T. Van Zele;S. Claeys;P. Gevaert;G. Van Maele

  • Total and specific IgE in nasal polyps is related to local eosinophilic inflammation.

    Claus Bachert;Philippe Gevaert;Gabriele Holtappels;S.G.O. Johansson

  • Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial

    Claus Bachert;Claus Bachert;Leda Mannent;Robert M Naclerio;Joaquim Mullol

  • Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

    Philippe Gevaert;Lien Calus;Thibaut Van Zele;Katrien Blomme

  • Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis.

    Philippe Gevaert;Nicholas Van Bruaene;Tom Cattaert;Kristel Van Steen

  • Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.

    Philippe Gevaert;Theodore A. Omachi;Jonathan Corren;Joaquim Mullol

  • Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis.

    Thibaut Van Zele;Philippe Gevaert;Jean-Baptiste Watelet;Geert Claeys

  • Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps.

    Philippe Gevaert;Doris Lang-Loidolt;Andreas Lackner;Heinz Stammberger

  • Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial.

    Claus Bachert;Claus Bachert;Ana R. Sousa;Valerie J. Lund;Glenis K. Scadding

  • Oral steroids and doxycycline: two different approaches to treat nasal polyps.

    Thibaut Van Zele;Philippe Gevaert;Gabriele Holtappels;Achim Beule

  • Pathogenesis of chronic rhinosinusitis: Inflammation

    Koen Van Crombruggen;Nan Zhang;Philippe Gevaert;Peter Tomassen

  • T-cell regulation in chronic paranasal sinus disease

    Nicholas Van Bruaene;Claudina Angela Pérez-Novo;Tomasz M. Basinski;Thibaut Van Zele

  • Nasal Polyposis: From Cytokines to Growth:

    Claus Bachert;Philippe Gevaert;Gabriele Holtappels;Claude Cuvelier

  • Non‐allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology

    Unknown

  • EUFOREA Expert Board Meeting on Uncontrolled Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Biologics: Definitions and Management.

    Claus Bachert;Claus Bachert;Claus Bachert;Joe K. Han;Martin Wagenmann;Werner Hosemann

  • Role of staphylococcal superantigens in upper airway disease.

    Claus Bachert;Nan Zhang;Joke Patou;Thibaut van Zele

  • Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue.

    Philippe Gevaert;Gabriële Holtappels;Sgo Johansson;Claude Cuvelier

  • Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?

    Peter W Hellings;Wytske Johanna Fokkens;Cezmi Akdis;Claus Bachert

  • Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps

    Joke Patou;Philippe Gevaert;Thibaut Van Zele;Gabriele Holtappels

  • Omalizumab is effective in allergic and non-allergic patients with nasal polyps and asthma

    Philippe Gevaert;Lien Calus;Thibaut Van Zele;Katrien Blomme

Frequent Co-Authors

Claus Bachert
Claus Bachert Karolinska Institute
Gabriele Holtappels
Gabriele Holtappels Ghent University
Joaquim Mullol
Joaquim Mullol University of Barcelona
P. Van Cauwenberge
P. Van Cauwenberge Ghent University
Ioana Agache
Ioana Agache Transylvania University of Brașov
Ludger Klimek
Ludger Klimek Ghent University
Bart N. Lambrecht
Bart N. Lambrecht Ghent University
Sven Seys
Sven Seys KU Leuven
Elina Toskala
Elina Toskala Thomas Jefferson University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers, particularly in nursing and specialized medical fields. For students seeking a fast track into nursing, accelerated NP programs online offer an efficient pathway to becoming a Nurse Practitioner with advanced immunological knowledge and clinical skills.

For those without a nursing background, online ABSN programs for non nurses are designed to help students quickly transition into the nursing profession. These programs emphasize foundational medical and immunological sciences, preparing graduates for diverse healthcare roles.

Selecting the right program can be challenging. Many students prioritize accessibility, making the easiest accelerated nursing programs appealing options to gain credentials swiftly while still building critical expertise in immunology-related topics.

Additionally, pursuing practical nursing through easy LPN programs to get into offers a solid health care foundation. This pathway is often accessible and provides hands-on experience that complements immunology knowledge, positioning graduates for further advancement in the medical field.

Best Scientists Citing Philippe Gevaert

Trending Scientists

Recently Published Articles